In this EOSC-Life workshop “Sharing sensitive data – centralised, federated or hybrid?”, we will examine the pros and cons of data sharing approaches by taking a look at specific use cases in the life sciences domain.
While great progress has been made in recent years in the development of public health within the European Union (EU), the Covid-19 pandemic brought to light existing vulnerabilities in the European health response mechanism, from Member State incoordination to difficulties in manufacturing and accessing medicines, to EU research fragmentation and differences between corporate R&D choices and public health priorities.
For the first time in two years, ICPerMed is delighted to organise a physical meeting and to welcome you in Paris on October 5-6, 2022 for the ICPerMed Conference – Prelude to the Future of Medicine.
The drug repurposing field has shifted after stepping into the limelight during the global COVID-19 pandemic. The world is beginning to care about drug repurposing and is recognising the opportunities to repurpose a drug to treat an often rare and neglected condition.
Repurposing schemes, projects and ideas are all in place to accelerate access to desperately needed medicines - the answers have been right under our noses all along!
EU-AMRI is organising a one-hour side event at ICRI 2022, held in Brno (Czech Republic). With actual case scenarios in the field of scientific health research, EU-AMRI wants to shine a light on national and international collaborations creating synergies between Research Infrastructures.
On 15 and 16 November 2022 the 4th EULAC PerMed Summer School will take place as a hybrid event, held in Panama City (Panama) and broadcasted online as well. The EULAC PerMed Summer School on clinical studies in Personalised Medicine aims for junior researchers and personalised medicine stakeholders, and has a specific focus on illustrating clinical studies’ gaps and challenges under different disease perspectives: infectious and neglected diseases, oncology diseases, cardiovascular and rare diseases.
On 17 and 18 November 2022 EULAC PerMed organises the third and final technical workshop on clinical trials in Personalised Medicine. The workshop will focus on the clinical trial designs applied in Personalised Medicine, exploring the advantages and challenges of the different designs through use cases. The workshop will also address the challenges and opportunities of multinational collaborations in Personalised Medicine.
ECRIN will host its 2nd CTU Day from 10-13h on 2 December 2022. The event is open to members of ECRIN national partner networks.
The program is in the process of finalisation but this years event will include feedback on the use of CTIS for multinational trials.
Stay tuned for registration and more program details
A one-and-a-half-day workshop is planned to take place in Kenya on the 13th and 14th July 2022 and will be hosted by the National Commission for Science Technology and Innovation (NACOSTI. The stakeholder workshop aims to bring together key stakeholders from the East African region (Kenya, Tanzania, Uganda, Rwanda and Ethiopia)
DATE: 12 July, 2022 – 10AM-11:30AM CEST, Online Event
The ISIDORe consortium has recently launched its first call to support research on SARS-CoV-2 and COVID-19. It provides free of charge access to more than 300 services from ISIDORe’s integrated portfolio of cutting-edge research services dedicated to epidemic-prone disease research.
It will follow in coming weeks with a new access call dedicated to the Monkeypox virus.
The European Conference on Rare Diseases & Orphan Products (ECRD) is recognised globally as the largest, patient-led rare disease event in which collaborative dialogue, learning and conversation takes place, forming the groundwork to shape goal-driven rare disease policies and allow for important and innovative discussions on a national and an international level to take place.
See the programme
All are welcome to an open meeting to exchange national experiences on data sharing during the COVID-19 pandemic.
Meeting aims:
